HomePeripheral vascular diseaseRenal

Renal

View Category

Peripheral vascular disease

EuroPCR 2018 | SPYRAL HTN-ON MED: Renal Denervation Comes Back to Life

After several trials with neutral outcomes, renal denervation had been demoted for some time. However, this new...
solaci -
Learn More
Aorta

What’s New in the European Guidelines on Peripheral Arterial Disease

Since the last version of the European guidelines on the diagnosis and treatment of peripheral arterial disease...
solaci -
Learn More
Aorta

What is the effect of statins on amputations, and survival in peripheral vascular disease?

The prevalence of peripheral arterial disease is between 15% and 20% of patients older than 65 years...
solaci -
Learn More
Medtronic educational sessions

Current Perspectives on Renal Denervation

Current Perspectives on Renal Denervation. Presenters: Dr. Lucio Padilla, Argentina.  Dr. Alejandro Ricalde, México.  Dr. Humberto Casal, Venezuela. This video, sponsored and...
solaci -
Learn More
Peripheral vascular disease

An Important Study Shows That Renal Function Must Be Cared for in TAVR

Courtesy of Dr. Carlos Fava. The presence of renal dysfunction in the “real world” is over 25% in patients...
solaci -
Learn More
Peripheral vascular disease

A New Opportunity for Renal Denervation

Courtesy of dr. Carlos Fava. At first, renal denervation enjoyed a considerable boost because, according to early studies,...
solaci -
Learn More
Peripheral vascular disease

The need for dialysis after TAVR increases mortality

Courtesy of Dr. Carlos Fava. Stage III or higher renal impairment is frequent before TAVR, and the need for...
solaci -
Learn More
HIGHLIGHTS

SPYRAL HTN-OFF MED: Renal Denervation Reloaded?

This work presented at the ESC Congress 2017 held in Barcelona, simultaneously published in The Lancet, seems to...
solaci -
Learn More